Compared with paracancerous tissues, METTL3 expression was higher in cervical cancer tissues; METTL3 overexpression was closely associated with higher FIGO stage as well as poorer pelvic lymph node metastasis, 5-year recurrence-free survival, distant-metastasis-free survival, progression-free survival, and overall survival, and was an independent indicator of poor prognosis for patients with early-stage cervical cancer [133]. The gene discussed is METTL3; the disease is cervical carcinoma.